Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03033420
Other study ID # RADMIS
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 15, 2017
Est. completion date May 1, 2021

Study information

Verified date September 2022
Source Psychiatric Centre Rigshospitalet
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Unipolar and bipolar disorder combined account for nearly half of all morbidity and mortality due to mental and substance use disorders, and burden society with the highest health care costs of all psychiatric and neurological disorders. Among these, costs due to psychiatric hospitalization is a major burden. Smartphones comprise an innovative and unique platform for monitoring and treatment of depression and mania. The RADMIS trials use a randomized controlled single-blind parallel-group design. Patients with unipolar or bipolar disorder discharged from psychiatric hospitals in The Capital Region of Denmark are invited to participate. Patients are at discharge from the psychiatric hospitals randomized, separately according to psychiatric diagnosis (thus, the RADMIS trial consists of two separate trials according to diagnosis, bipolar disorder or unipolar disorder), to: 1) a smartphone-based monitoring system including a) an integrated feedback loop between patients and clinicians and b) context-aware CBT modules (intervention group) or 2) treatment-as-usual (control group) for a 6-months trial period. The trial is started in March 2017. The outcomes are 1) differences in the number and duration of re-admissions between the intervention group and the control group (primary), 2) differences in severity of depressive and manic symptoms (manic symptoms only for patients with bipolar disorder); differences in psychosocial functioning; and differences in number of affective episodes between the intervention group and the control group (secondary), and 3) differences in perceived stress, quality of life, self-rated depressive symptoms, self-rated manic symptoms (only for patients with bipolar disorder), recovery, empowerment, adherence to medication, well-being, ruminations, worrying, and satisfaction between the intervention group and the control group (tertiary).


Description:

Background Unipolar and bipolar disorder combined account for nearly half of all morbidity and mortality due to mental and substance use disorders, and burden society with the highest health care costs of all psychiatric and neurological disorders. Among these, costs due to psychiatric hospitalization are a major burden. Smartphones comprise an innovative and unique platform for monitoring and treatment of depression and mania. No prior trial has investigated whether the use of a smartphone-based system can prevent re-admission among patients discharged from hospital. Methods The RADMIS trials use a randomized controlled single-blind parallel-group design. Patients with unipolar disorder and patients with bipolar disorder are invited to participate in each their trial when discharged from psychiatric hospitals in The Capital Region of Denmark following an affective episode and randomized to either 1) a smartphone-based monitoring system including a) an integrated feedback loop between patients and clinicians and b) context-aware CBT modules (intervention group) or 2) standard treatment (control group) for a 6-months trial period. The trial is started in March 2017. The outcomes are 1) differences in the number and duration of re-admissions between the intervention group and the control group (primary), 2) differences in severity of depressive and manic symptoms (manic symptoms only for patients with bipolar disorder); differences in psychosocial functioning; and differences in number of affective episodes between the intervention group and the control group (secondary), and 3) differences in perceived stress, quality of life, self-rated depressive symptoms, self-rated manic symptoms (only for patients with bipolar disorder), recovery, empowerment, adherence to medication, well-being, ruminations, worrying, and satisfaction between the intervention group and the control group (tertiary). Analysis Recruitment is ongoing. Discussion If the smartphone-based monitoring system is proved effective in reducing the rate and duration of re-admissions there will be basis for using a system of this kind in the treatment of unipolar and bipolar disorder in general and in a larger scale.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date May 1, 2021
Est. primary completion date March 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Unipolar disorder or bipolar disorder diagnoses according to ICD-10 - Patients who are discharged from a psychiatric hospital in The Capital Region of Denmark following an affective episode (depression or mania) Exclusion Criteria: - Pregnancy - A lack of Danish language skills

Study Design


Intervention

Device:
A smartphone-based monitoring system including a) an integrated feedback loop between patients and clinicians and b) context-aware CBT modules
A smartphone-based monitoring system including a) an integrated feedback loop between patients and clinicians and b) context-aware CBT modules

Locations

Country Name City State
Denmark Psychiatric Center Copenhagen, Rigshospitalet Copenhagen

Sponsors (2)

Lead Sponsor Collaborator
Psychiatric Centre Rigshospitalet Technical University of Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Perceived stress Differences in perceived stress (The Cohen's Perceived stress scale) between the intervention group and the control group. 6 months trial period
Other Quality of life Differences in quality of life (The WHO Quality of Life-BREF) between the intervention group and the control group. 6 months trial period
Other Self-rated manic symptoms Differences in self-rated manic symptoms (The Altman Self Rating scale for Mania) between the intervention group and the control group. 6 months trial period
Other Self-rated depressive symptoms Differences in self-rated depressive symptoms (The Becks Depressive Inventory) between the intervention group and the control group. 6 months trial period
Other Self-rated depressive symptoms Differences in self-rated depressive symptoms (The Hamilton Depression Self-rating Scale 6-item) between the intervention group and the control group. 6 months trial period
Other Recovery Differences in recovery (The Recovery Assessment Scale) between the intervention group and the control group. 6 months trial period
Other Empowerment Differences in empowerment (Rogers empowerment scale) between the intervention group and the control group. 6 months trial period
Other Adherence to medication Differences in adherence to medication (The Medicine Adherence Rating Scale) between the intervention group and the control group. 6 months trial period
Other Well-being Differences in well-being according (The WHO (five) well-being index) between the intervention group and the control group. 6 months trial period
Other Rumination Differences in rumination (The Rumination Response Scale) between the intervention group and the control group. 6 months trial period
Other Worrying Differences in worrying (The Penn State Worry Questionnaire) between the intervention group and the control group. 6 months trial period
Other Satisfaction Differences in satisfaction (The Verona Satisfaction Scale-Affective Disorder) between the intervention group and the control group. 6 months trial period
Primary Number of re-admissions Differences in the number of re-admissions between the intervention group and the control group. Data will be collected from Danish registers. 6 months trial period
Primary Duration of re-admissions Differences in the duration of re-admissions between the intervention group and the control group. 6 months trial period
Secondary Severity of depressive symptoms Differences in the severity of depressive (The Hamilton Depression Rating Scale) symptoms between the intervention group and the control group. 6 months trial period
Secondary Severity of manic symptoms Differences in the severity of manic (The Young Mania Rating Scale) symptoms between the intervention group and the control group. 6 months trial period
Secondary Psychosocial functioning Differences in psychosocial functioning (The Psychosocial Functioning Assessment Short Test - FAST) between the intervention group and the control group. 6 months trial period
Secondary Number of affective episodes Differences in the number of affective episodes between the intervention group and the control group. 6 months trial period
See also
  Status Clinical Trial Phase
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT02855762 - Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder N/A
Recruiting NCT05915013 - Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response Phase 1
Recruiting NCT05206747 - Ottawa Sunglasses at Night for Mania Study N/A
Completed NCT02513654 - Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects Phase 1
Recruiting NCT06313918 - Exercise Therapy in Mental Disorders-study N/A
Completed NCT02304432 - Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine Early Phase 1
Recruiting NCT06197048 - Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder N/A
Completed NCT03497663 - VIA Family - Family Based Early Intervention Versus Treatment as Usual N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT02212041 - Electronic Cigarettes in Smokers With Mental Illness N/A
Recruiting NCT05030272 - Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings N/A
Recruiting NCT04298450 - ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention N/A
Active, not recruiting NCT03641300 - Efficacy of Convulsive Therapies for Bipolar Depression N/A
Not yet recruiting NCT04432116 - Time and Virtual Reality in Schizophrenia and Bipolar Disorder N/A
Terminated NCT02909504 - Gao NARASD Lithium Study Phase 4
Terminated NCT02893371 - Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Completed NCT02970721 - Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
Recruiting NCT02481245 - BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study Phase 2
Recruiting NCT03088657 - Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study